ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PRINCIPLE CAPABLE OF BEING SUBJECTED TO HIGH EFFECT DURING ITS FIRST PASSAGE THROUGH THE INTESTINE

Details for Australian Patent Application No. 2002334009 (hide)

Owner GATTEFOSSE HOLDING

Inventors JANNIN, Vincent; ROULOT, Delphine; BENAMEUR, Hassan

Pub. Number AU-A-2002334009

PCT Number PCT/FR02/02566

PCT Pub. Number WO2003/011207

Priority 0110094 27.07.01 FR

Filing date 18 July 2002

Wipo publication date 17 February 2003

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 0110094 27.07.01 FR

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002334009

6 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334010-IMPROVED CUTTING INSTRUMENT

2002334008-COMMUNICATION METHOD FOR CONTROLLED DATA EXCHANGE BETWEEN A CLIENT TERMINAL AND A HOST SITE NETWORK AND PROTECTIVE SERVER SET THEREFOR